-
Mashup Score: 0
“Opportunity wise, I always say that if you don’t perform the test, then you’re limiting treatment options for your patients,” says Kara Cossis, PA-C, MPH.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 6Jason Hafron, MD, on the importance of patient selection in the new era of bladder cancer treatment - 1 day(s) ago
“It’s a little tedious to find these patients, but it’s really critical. Otherwise, you’re not going to get reimbursed for these therapies,” says Jason Hafron, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet-
Jason Hafron, MD, (@HafronJason) discusses the importance of patient selection in the new era of bladder cancer treatment. #LUGPA2024 @HealthSolaris https://t.co/MyuLN3PjiQ
-
-
Mashup Score: 1
“When we look at focal therapy in general, the better we’re able to see, localize, identify and risk stratify prostate cancers, the better we’re able to treat them and offer more personalized and focal treatments,” says Arvin George, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet-
Focal therapy’s future in prostate cancer is bright, says Arvin K. George, MD (@arvinkgeorge). | #LUGPA2024 @brady_urology @UrologyUS https://t.co/7HH7kAynSI
-
-
Mashup Score: 5Gautam Jayram, MD, on key trends in bladder, kidney cancer - 2 day(s) ago
“We then talked a little bit about BCG unresponsive disease, which is a really hot topic,” says Gautam Jayram, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet-
Gautam Jayram, MD, (@TomJayram) highlights key trends in bladder and kidney cancer. #LUGPA2024 @UrologyUS @UA_Nashville https://t.co/cbipkahcbL
-
-
Mashup Score: 3
“We’re really excited as robotic surgeons, because this will be the first time in a couple decades that there’ll be competition for robots, and that’s only going to make things better,” says Ronney Abaza, MD, FACS.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet-
Ronney Abaza, MD, FACS, (@DrRonneyAbaza) recaps his #LUGPA2024 presentation, “What’s New in Robotic Surgery?” @UrologyUS https://t.co/QNL68xm5VN
-
-
Mashup Score: 4
In this episode of Speaking of Urology, former MLB player Dave Winfield shares lessons he’s learned throughout his professional baseball career and his work in philanthropy.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet-
Dave Winfield (@DaveWinfieldHOF) delivered a keynote presentation at #LUGPA2024 on lessons learned from baseball and philanthropy. In a podcast episode with Urology Times, he highlights key takeaways from this discussion and more. @UrologyUS Listen here: https://t.co/CMRpXwJXkp
-
-
Mashup Score: 5
“The guidelines have changed. They used to be called third-line therapies, and they’re no longer, quote “third-line” anymore, based on the new guidelines that have come out,” says Kari Bailey, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet-
“The guidelines have changed. They used to be called third-line therapies, and they're no longer quote "third-line" anymore, based on the new guidelines that have come out,” says Kari Bailey, MD, on advanced therapies in OAB. #LUGPA2024 @UrologyUS https://t.co/OnYXmXrPdW
-
-
Mashup Score: 2
“You have to be balanced in what to embrace vs what not. It is easy to be wowed by new things,” Scott Eggener, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet-
Scott Eggener, MD, (@uroegg) discusses a pragmatic approach to prostate cancer innovations. #LUGPA2024 #pcsm @UrologyUS @UChicagoUrology https://t.co/R360FFFNWr
-
-
Mashup Score: 3
“Part of the reason that we created this Working Group Session is to essentially highlight the role that APPs can play in building men’s health practices,” says Andrew Y. Sun, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet-
Andrew Y. Sun, MD, (@AndrewSunMD) recaps a #LUGPA2024 session on integrating APPs in men’s health. @UrologyUS #urology https://t.co/j2Z9XHgYic
-
-
Mashup Score: 18
“I would say, about 10 years ago, there was a real skepticism, a healthy skepticism, I would say, in the beginning. Now that has slowly changed into optimism,” says Arvin K. George, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet-
Arvin K. George, MD, (@arvinkgeorge) describes how the adoption of focal therapy has evolved over the past few years. #pcsm #LUGPA2024 @UrologyUS @brady_urology https://t.co/idYtdXzWmV
-
Kara Cossis, PA-C, MPH, discusses challenges and opportunities with genetic testing in prostate cancer. #pcsm @ChesUrology https://t.co/8xaZPUVMeK